United States Patent and Trademark Office (USPTO) Public Awareness campaign strategy on the dangers of counterfeit substances or devices
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
United States Patent and Trademark Office (USPTO) Public Awareness campaign strategy on the dangers of counterfeit substances or devices
This is a ptag sources sought request for information (rfi) only.
in accordance with the patent and trademark office efficiency act (ptoea), 35 u.s.c. § 2(b)(4)(a), this sources sought notice request for information) (rfi) is strictly for market research only. it is for informational and planning purposes and shall not be construed as a solicitation or as an obligation or commitment by the government at this time.
this rfi is being made available under naics 541820 - public relations agencies.
this effort is for campaign services to support a nationwide public awareness campaign to highlight the dangers of counterfeit pharmaceuticals and medical devices.
the uspto is seeking information from qualified vendors regarding capabilities and relevant experience to support potential public relations services to create and execute a nationwide public awareness campaign consisting of media relations, videos, and other creative communications deliverables including a microsite and social media campaign to highlight the dangers of counterfeit pharmaceuticals and medical devices that are falsely represented as products made or distributed by real pharmaceutical and medical device companies.
submission instructions:
questions due: no later than october 26, 2026 at 1pm et
rfi response due date: november 6, 2026 10am et
all details are located within the pdf attachment.
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Chemicals, Healthcare and Medicine